Pegloticase Intravenous and Von willebrand factor recombinant Intravenous
Determining the interaction of Pegloticase Intravenous and Von willebrand factor recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pegloticase
Brand name: Krystexxa
Synonyms: Pegloticase
Generic Name: von willebrand factor
Brand name: Vonvendi, Wilfactin
Synonyms: Von Willebrand factor (recombinant), von Willebrand Factor (Recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pegloticase Intravenous-Vonvendi
- Pegloticase Intravenous-Vopac
- Pegloticase Intravenous-Vopac MDS
- Pegloticase Intravenous-Vorapaxar
- Pegloticase Intravenous-Vorapaxar Sulfate
- Pegloticase Intravenous-Voraxaze
- Von willebrand factor recombinant Intravenous-Pegvaliase
- Von willebrand factor recombinant Intravenous-Pegvaliase-pqpz
- Von willebrand factor recombinant Intravenous-Pegvaliase-pqpz Subcutaneous
- Von willebrand factor recombinant Intravenous-Pegvisomant
- Von willebrand factor recombinant Intravenous-Pegvisomant Subcutaneous
- Von willebrand factor recombinant Intravenous-Pembrolizumab